Contacto

Human Procollagen I N-Terminal Propeptide (PINP) CLIA Kit

743,75 (96 tests)

Human Procollagen I N-Terminal Propeptide (PINP) CLIA Kit is a Sandwich CLIA Kit for use with Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

Proveedor

Abbexa

Reference

abx492263

Tested Applications

CLIA

Reactivity

Human

Status

RUO

Si quieres saber los precios con descuentos por volumen o bien más características del producto, contáctanos!

Características de producto

tested_applications
CLIA
reactivity
Human
category
CLIA Kits
Immunogen / Target
Procollagen I N-Terminal Propeptide (PINP)
size_1
96 tests
size_2
5 × 96 tests
size_3
10 × 96 tests
storage
Shipped at 4 °C. Upon receipt, store the kit according to the storage instruction in the kit's manual.
test_range
6.86 pg/ml - 5000 pg/ml
sensitivity
< 2.56 pg/ml
detection_method
Chemiluminescent
assay_type
Sandwich
assay_data
Quantitative
availability
Shipped within 5-20 working days.
dry_ice
No
note
This product is for research use only.

The range and sensitivity is subject to change. Please contact us for the latest product information. For accurate results, sample concentrations must be diluted to mid-range of the kit. If you require a specific range, please contact us in advance or write your request in your order comments.

Please note that our ELISA and CLIA kits are optimised for detection of native samples, rather than recombinant proteins. We are unable to guarantee detection of recombinant proteins, as they may have different sequences or tertiary structures to the native protein.
background
Type I Collagen is a triple-stranded polymeric protein complex formed from two COL1A1 strands and one COL1A2 strand. It provides structural strength to various parts of the body, including the eyes, bones, and tendons. Type I collagen is also found in large amounts in scar tissue. The C- and N-terminals of COL1A1 (PICP and PINP) are used as biomarkers of bone turnover. Mutations in the type I collagen genes are associated with osteogenesis imperfecta and Ehlers-Danlos syndrome. Target